Quinn Opportunity Partners’s Lifecore Biomedical LFCR Stock Holding History

Quinn Opportunity Partners’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.69M	Buy	453,495 +210,825	+87%	+$1.46M	0.09%	175
2025 Q4	$1.99M	Buy	242,670 +58,189	+32%	+$430K	0.09%	177
2025 Q3	$1.36M	Sell	184,481 -17,771	-9%	-$134K	0.1%	163
2025 Q2	$1.64M	Buy	202,252 +48,806	+32%	+$329K	0.14%	148
2025 Q1	$1.08M	Buy	153,446 +25,542	+20%	+$159K	0.08%	205
2024 Q4	$950K	Hold	127,904	–	–	0.07%	208
2024 Q3	$631K	Buy	127,904 +19,920	+18%	+$104K	0.06%	177
2024 Q2	$554K	Buy	107,984 +13,171	+14%	+$78K	0.06%	167
2024 Q1	$503K	Buy	+94,813	New	+$678K	0.06%	171

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return